Dr. Reddy's Laboratories Limited Stock price NSE India S.E.
Equities
DRREDDY
INE089A01023
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6,205 INR | -2.14% | -1.52% | +7.05% |
Sales 2024 * | 278B 3.36B | Sales 2025 * | 298B 3.59B | Capitalization | 1,056B 12.73B |
---|---|---|---|---|---|
Net income 2024 * | 54.46B 657M | Net income 2025 * | 56.36B 680M | EV / Sales 2024 * | 3.53 x |
Net cash position 2024 * | 72.87B 879M | Net cash position 2025 * | 112B 1.35B | EV / Sales 2025 * | 3.17 x |
P/E ratio 2024 * |
19.4
x | P/E ratio 2025 * |
18.7
x | Employees | 25,863 |
Yield 2024 * |
0.64% | Yield 2025 * |
0.66% | Free-Float | 91.47% |
Latest transcript on Dr. Reddy's Laboratories Limited
1 day | -2.12% | ||
1 week | -1.52% | ||
Current month | -3.39% | ||
1 month | -3.28% | ||
3 months | +10.09% | ||
6 months | +10.53% | ||
Current year | +7.05% |
Managers | Title | Age | Since |
---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 57 | 18-04-01 |
Parag Agarwal
DFI | Director of Finance/CFO | - | 20-11-01 |
Chairman | 56 | 93-01-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gunupati Prasad
CHM | Chairman | 63 | 86-04-07 |
Chairman | 56 | 93-01-17 | |
Kalpana Morparia
BRD | Director/Board Member | 73 | 07-06-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-19 | 6,205 | -2.14% | 92 647 |
24-03-18 | 6,341 | +0.89% | 180,493 |
24-03-15 | 6,285 | -0.15% | 485,947 |
24-03-14 | 6,295 | -0.15% | 400,212 |
24-03-13 | 6,304 | +0.03% | 210,265 |
Delayed Quote NSE India S.E., March 19, 2024 at 02:01 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.83% | 687B | |
+30.96% | 595B | |
+0.01% | 378B | |
+15.18% | 316B | |
+11.39% | 308B | |
+0.78% | 211B | |
-6.09% | 208B | |
-2.92% | 203B | |
-3.72% | 157B |
- Stock
- Equities
- Stock Dr. Reddy's Laboratories Limited
- Stock Dr. Reddy's Laboratories Limited - NSE India S.E.